Descartes’ Study Shows 40% of Shippers and Logistics Services Providers Plan to Invest in Transportation Technology to Address Industry Changes 11-06-2024, 17:45

GA-ASI Flight Tests LEO SATCOM on MQ-9A 3-02-2023, 03:08

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00